Copyright Reports & Markets. All rights reserved.

Global Triptans for Migraine Headaches Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Triptans for Migraine Headaches Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Oral
    • 1.3.3 Subcutaneous Injection
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Triptans for Migraine Headaches Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital Pharmacies
    • 1.4.3 Drug Stores
  • 1.5 Global Triptans for Migraine Headaches Market Size & Forecast
    • 1.5.1 Global Triptans for Migraine Headaches Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Triptans for Migraine Headaches Sales Quantity (2020-2031)
    • 1.5.3 Global Triptans for Migraine Headaches Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 GSK
    • 2.1.1 GSK Details
    • 2.1.2 GSK Major Business
    • 2.1.3 GSK Triptans for Migraine Headaches Product and Services
    • 2.1.4 GSK Triptans for Migraine Headaches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 GSK Recent Developments/Updates
  • 2.2 Teva
    • 2.2.1 Teva Details
    • 2.2.2 Teva Major Business
    • 2.2.3 Teva Triptans for Migraine Headaches Product and Services
    • 2.2.4 Teva Triptans for Migraine Headaches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Teva Recent Developments/Updates
  • 2.3 Pfizer
    • 2.3.1 Pfizer Details
    • 2.3.2 Pfizer Major Business
    • 2.3.3 Pfizer Triptans for Migraine Headaches Product and Services
    • 2.3.4 Pfizer Triptans for Migraine Headaches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Pfizer Recent Developments/Updates
  • 2.4 Novartis
    • 2.4.1 Novartis Details
    • 2.4.2 Novartis Major Business
    • 2.4.3 Novartis Triptans for Migraine Headaches Product and Services
    • 2.4.4 Novartis Triptans for Migraine Headaches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Novartis Recent Developments/Updates
  • 2.5 Sun Pharma
    • 2.5.1 Sun Pharma Details
    • 2.5.2 Sun Pharma Major Business
    • 2.5.3 Sun Pharma Triptans for Migraine Headaches Product and Services
    • 2.5.4 Sun Pharma Triptans for Migraine Headaches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Sun Pharma Recent Developments/Updates
  • 2.6 Grunenthal
    • 2.6.1 Grunenthal Details
    • 2.6.2 Grunenthal Major Business
    • 2.6.3 Grunenthal Triptans for Migraine Headaches Product and Services
    • 2.6.4 Grunenthal Triptans for Migraine Headaches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Grunenthal Recent Developments/Updates
  • 2.7 Endo Pharmaceuticals
    • 2.7.1 Endo Pharmaceuticals Details
    • 2.7.2 Endo Pharmaceuticals Major Business
    • 2.7.3 Endo Pharmaceuticals Triptans for Migraine Headaches Product and Services
    • 2.7.4 Endo Pharmaceuticals Triptans for Migraine Headaches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Endo Pharmaceuticals Recent Developments/Updates
  • 2.8 Merck
    • 2.8.1 Merck Details
    • 2.8.2 Merck Major Business
    • 2.8.3 Merck Triptans for Migraine Headaches Product and Services
    • 2.8.4 Merck Triptans for Migraine Headaches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Merck Recent Developments/Updates
  • 2.9 Johnson & Johnson
    • 2.9.1 Johnson & Johnson Details
    • 2.9.2 Johnson & Johnson Major Business
    • 2.9.3 Johnson & Johnson Triptans for Migraine Headaches Product and Services
    • 2.9.4 Johnson & Johnson Triptans for Migraine Headaches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Johnson & Johnson Recent Developments/Updates

3 Competitive Environment: Triptans for Migraine Headaches by Manufacturer

  • 3.1 Global Triptans for Migraine Headaches Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Triptans for Migraine Headaches Revenue by Manufacturer (2020-2025)
  • 3.3 Global Triptans for Migraine Headaches Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Triptans for Migraine Headaches by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Triptans for Migraine Headaches Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Triptans for Migraine Headaches Manufacturer Market Share in 2024
  • 3.5 Triptans for Migraine Headaches Market: Overall Company Footprint Analysis
    • 3.5.1 Triptans for Migraine Headaches Market: Region Footprint
    • 3.5.2 Triptans for Migraine Headaches Market: Company Product Type Footprint
    • 3.5.3 Triptans for Migraine Headaches Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Triptans for Migraine Headaches Market Size by Region
    • 4.1.1 Global Triptans for Migraine Headaches Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Triptans for Migraine Headaches Consumption Value by Region (2020-2031)
    • 4.1.3 Global Triptans for Migraine Headaches Average Price by Region (2020-2031)
  • 4.2 North America Triptans for Migraine Headaches Consumption Value (2020-2031)
  • 4.3 Europe Triptans for Migraine Headaches Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Triptans for Migraine Headaches Consumption Value (2020-2031)
  • 4.5 South America Triptans for Migraine Headaches Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Triptans for Migraine Headaches Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Triptans for Migraine Headaches Sales Quantity by Type (2020-2031)
  • 5.2 Global Triptans for Migraine Headaches Consumption Value by Type (2020-2031)
  • 5.3 Global Triptans for Migraine Headaches Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Triptans for Migraine Headaches Sales Quantity by Application (2020-2031)
  • 6.2 Global Triptans for Migraine Headaches Consumption Value by Application (2020-2031)
  • 6.3 Global Triptans for Migraine Headaches Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Triptans for Migraine Headaches Sales Quantity by Type (2020-2031)
  • 7.2 North America Triptans for Migraine Headaches Sales Quantity by Application (2020-2031)
  • 7.3 North America Triptans for Migraine Headaches Market Size by Country
    • 7.3.1 North America Triptans for Migraine Headaches Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Triptans for Migraine Headaches Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Triptans for Migraine Headaches Sales Quantity by Type (2020-2031)
  • 8.2 Europe Triptans for Migraine Headaches Sales Quantity by Application (2020-2031)
  • 8.3 Europe Triptans for Migraine Headaches Market Size by Country
    • 8.3.1 Europe Triptans for Migraine Headaches Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Triptans for Migraine Headaches Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Triptans for Migraine Headaches Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Triptans for Migraine Headaches Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Triptans for Migraine Headaches Market Size by Region
    • 9.3.1 Asia-Pacific Triptans for Migraine Headaches Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Triptans for Migraine Headaches Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Triptans for Migraine Headaches Sales Quantity by Type (2020-2031)
  • 10.2 South America Triptans for Migraine Headaches Sales Quantity by Application (2020-2031)
  • 10.3 South America Triptans for Migraine Headaches Market Size by Country
    • 10.3.1 South America Triptans for Migraine Headaches Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Triptans for Migraine Headaches Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Triptans for Migraine Headaches Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Triptans for Migraine Headaches Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Triptans for Migraine Headaches Market Size by Country
    • 11.3.1 Middle East & Africa Triptans for Migraine Headaches Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Triptans for Migraine Headaches Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Triptans for Migraine Headaches Market Drivers
  • 12.2 Triptans for Migraine Headaches Market Restraints
  • 12.3 Triptans for Migraine Headaches Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Triptans for Migraine Headaches and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Triptans for Migraine Headaches
  • 13.3 Triptans for Migraine Headaches Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Triptans for Migraine Headaches Typical Distributors
  • 14.3 Triptans for Migraine Headaches Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Triptans for Migraine Headaches market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    Triptans are a family of tryptamine-based drugs used as abortive medication in the treatment of migraines and cluster headaches.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Triptans for Migraine Headaches market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Triptans for Migraine Headaches market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Triptans for Migraine Headaches market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Triptans for Migraine Headaches market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Triptans for Migraine Headaches market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Triptans for Migraine Headaches
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Triptans for Migraine Headaches market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Teva, Pfizer, Novartis, Sun Pharma, Grunenthal, Endo Pharmaceuticals, Merck, Johnson & Johnson, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Triptans for Migraine Headaches market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Oral
    Subcutaneous Injection
    Others
    Market segment by Application
    Hospital Pharmacies
    Drug Stores
    Major players covered
    GSK
    Teva
    Pfizer
    Novartis
    Sun Pharma
    Grunenthal
    Endo Pharmaceuticals
    Merck
    Johnson & Johnson
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Triptans for Migraine Headaches product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Triptans for Migraine Headaches, with price, sales quantity, revenue, and global market share of Triptans for Migraine Headaches from 2020 to 2025.
    Chapter 3, the Triptans for Migraine Headaches competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Triptans for Migraine Headaches breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Triptans for Migraine Headaches market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Triptans for Migraine Headaches.
    Chapter 14 and 15, to describe Triptans for Migraine Headaches sales channel, distributors, customers, research findings and conclusion.

    Buy now